Galectin Therapeutics Inc (GALT)

3.48 +0.14 (+4.19%) USD  |  NASDAQ  |  May 06, 16:00
3.49 +0.01 (+0.29%) After-Hours: 20:00
More

Galectin Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
April 01, 2024 --
November 14, 2023 --
March 31, 2023 --
May 17, 2022 --
April 01, 2022 --
Date Value
November 16, 2021 --
August 17, 2021 --
May 18, 2021 --
April 16, 2021 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Apr 16 2021
--
Maximum
Apr 16 2021
--
Average
--
Median
Apr 16 2021

Revenue Estimates for Current Fiscal Year Benchmarks

Madrigal Pharmaceuticals Inc Upgrade
Viking Therapeutics Inc Upgrade
89bio Inc Upgrade
Terns Pharmaceuticals Inc Upgrade
Enanta Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade